ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
64,049.90
-0.30%
S&P 500
5,464.62
-0.16%
Dow Jones
39,150.33
0.04%
US Dollar vs Yen
159.775
0.00%
Brent Oil
84.39
0.00%
Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Eiger Biopharmaceuticals Com (CLDN)

  7. Eiger Biopharmaceuticals Com (CLDN) ニュース

CLDN

CELLADON CORP (CLDN)

Eiger Biopharmaceuticals Com
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:CLDN
日付受信時刻ニュースソース見出しコード企業名
2016/03/2608 : 21Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CLDNEiger Biopharmaceuticals Com
2016/03/2608 : 19Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CLDNEiger Biopharmaceuticals Com
2016/03/2608 : 17Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CLDNEiger Biopharmaceuticals Com
2016/03/2608 : 15Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CLDNEiger Biopharmaceuticals Com
2016/03/2608 : 11Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CLDNEiger Biopharmaceuticals Com
2016/03/2608 : 08Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CLDNEiger Biopharmaceuticals Com
2016/03/2608 : 06Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CLDNEiger Biopharmaceuticals Com
2016/03/2319 : 12Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CLDNEiger Biopharmaceuticals Com
2016/03/2205 : 19Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CLDNEiger Biopharmaceuticals Com
2016/03/2205 : 05GlobeNewswire Inc.Celladon Announces Results of Special MeetingNASDAQ:CLDNEiger Biopharmaceuticals Com
2016/03/1505 : 12Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:CLDNEiger Biopharmaceuticals Com
2016/03/1006 : 39Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CLDNEiger Biopharmaceuticals Com
2016/03/1006 : 37Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:CLDNEiger Biopharmaceuticals Com
2016/03/0107 : 27Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CLDNEiger Biopharmaceuticals Com
2016/02/2922 : 00PR Newswire (US)Eiger to Participate in Cowen & Company 2016 Health Care ConferenceNASDAQ:CLDNEiger Biopharmaceuticals Com
2016/02/1704 : 44Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:CLDNEiger Biopharmaceuticals Com
2016/02/1704 : 44Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CLDNEiger Biopharmaceuticals Com
2016/02/1701 : 29Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CLDNEiger Biopharmaceuticals Com
2016/02/1620 : 20Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CLDNEiger Biopharmaceuticals Com
2016/02/1620 : 19Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:CLDNEiger Biopharmaceuticals Com
2016/02/1620 : 01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CLDNEiger Biopharmaceuticals Com
2016/02/1207 : 31Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CLDNEiger Biopharmaceuticals Com
2016/02/1207 : 18Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CLDNEiger Biopharmaceuticals Com
2016/02/1107 : 16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CLDNEiger Biopharmaceuticals Com
2016/02/1107 : 15Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:CLDNEiger Biopharmaceuticals Com
2016/02/1106 : 58GlobeNewswire Inc.Celladon Sets Date for Special Meeting of StockholdersNASDAQ:CLDNEiger Biopharmaceuticals Com
2016/02/0907 : 25Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:CLDNEiger Biopharmaceuticals Com
2016/01/2921 : 28Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CLDNEiger Biopharmaceuticals Com
2016/01/2220 : 12Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:CLDNEiger Biopharmaceuticals Com
2016/01/2006 : 08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CLDNEiger Biopharmaceuticals Com
 Showing the most relevant articles for your search:NASDAQ:CLDN

最近閲覧した銘柄

BOV
SOJA3F
Boa Safra Sementes ON
POLO
KINGUSDT
KING
EU
RCVBB
Centre Loire Valley Dome...
COIN
EDCCCUSD
EDC Blockchain
NASDAQI
CX502020GI
OMX Copenhagen Electroni...
TG
SKC2
Standard Bank
USOTC
CSOL
China Solar and Clean En... (PK)
NYSE
JCE
Nuveen Core Equity Alpha
BIT
P21126
NLBNPIT21126 20991231 3....
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有